Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of addiction medicine"
DOI: 10.1097/adm.0000000000001136
Abstract: OBJECTIVES Persons with opioid use disorder (OUD) suffer disproportionately from morbidity and mortality related to serious addiction-related infections requiring hospitalization. Long-acting buprenorphine (LAB) is an underused medication for OUD that may facilitate linkage to care… read more here.
Keywords: including methadone; agonist opioids; low dose; buprenorphine ... See more keywords